1161837

Xellia Pharmaceuticals USA LLC — FEI 3012279857

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 7, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bedford, OH (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed